ANI Pharmaceuticals is building a leading Rare Disease company focused on Serving Patients, Improving Lives
ANI Pharmaceuticals Announces Offer to Acquire Egetis Therapeutics, Expanding the Scope and Scale of Its Rare Disease Business
2026-11-05
$71.81
+ 1.82 (2.6%)
Pricing delayed by 20 minutes
Last updated
2026-11-18 13:30:00